Okay, let's tackle this question about the most important good prognostic factor for neuroblastoma. First, I need to recall what I know about neuroblastoma. It's a type of cancer that occurs in nerve tissue, usually in children. Prognostic factors are things that help predict how well a patient will respond to treatment or their chances of survival.

The question is asking for the most important good prognostic factor. From what I remember, several factors influence prognosis in neuroblastoma, including age at diagnosis, tumor stage, histology, and genetic factors like N-myc amplification. But which one is the most significant?

I think age is a critical factor. Younger children, especially those under 18 months, tend to have a better prognosis. This might be because their tumors are more likely to differentiate spontaneously or have a better response to treatment. Also, younger patients might have less aggressive tumor biology. Another factor could be the stage of the disease—localized tumors are easier to treat. Histology, like having a favorable histology, could also play a role. But I need to verify which is the most important.

Wait, I remember that in neuroblastoma, the International Neuroblastoma Risk Group (INRG) classification includes age as a key factor. Also, the presence of certain genetic markers like N-myc amplification is a poor prognostic factor, so the absence of that would be good. But the question is about the most important good factor.

Another angle: clinical trials and studies often highlight that age under 18 months is associated with better outcomes. For example, infants with neuroblastoma might have a higher chance of spontaneous regression, which is a unique feature of this cancer in very young patients. So age seems like a major factor.

Let me cross-check. The options weren't provided, but assuming the correct answer is age <18 months. The other options might include stage, histology, or other genetic factors. The key here is that age is the most important because it's a strong independent predictor. Even if other factors are present, a very young age can override some of them in terms of prognosis. So, putting it all together, the core concept is that neuroblastoma prognosis depends on multiple factors, but age at diagnosis is the most critical. The correct answer would be age less than 18 months. The other options, like stage or histology, are important but not as primary as age. Also, genetic factors like N-myc amplification are bad, so their absence is good, but again, age is more significant. I need to structure the explanation as per the user's instructions. Start with the core concept, explain why the correct answer is right, address each wrong option, give a clinical pearl, and end with the correct answer line. Make sure to use precise terms and keep it concise.

**Core Concept**
Neuroblastoma prognosis is influenced by age, tumor biology, and genetic markers. Age <18 months is the most critical favorable prognostic factor due to spontaneous tumor differentiation and better treatment response in infants. **Why the Correct Answer is Right** Age under 18 months correlates with improved survival in neuroblastoma, even in advanced stages. Infants often exhibit spontaneous regression or favorable tumor biology, possibly due to immature sympathetic nervous system development. This age threshold is a cornerstone of the International Neuroblast

✓ Correct Answer: D. CD44 expression